| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/08/1996 | WO1996003371A1 N-acyl-n-(substituted cinnamoyl)ethylenediamine derivative |
| 02/08/1996 | WO1996003141A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 02/08/1996 | WO1996003125A1 Carbon monoxide dependent guanylyl cyclase modifiers |
| 02/08/1996 | WO1996003122A2 Use of gabapentin in the treatment of anxiety and panic |
| 02/08/1996 | DE4428835A1 Neue 3-substituierte 3H-2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel New 3-substituted 3H-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 02/08/1996 | DE4427648A1 N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung N-Stubstituierte 3-azabicyclo [3,2,0,] heptane derivatives, their preparation and use |
| 02/08/1996 | DE4427647A1 N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung N-substituted Azabicycloheptan derivatives, their preparation and use |
| 02/08/1996 | CA2196046A1 Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors |
| 02/08/1996 | CA2195845A1 1,2-substituted imidazolyl compounds for the treatment of inflammation |
| 02/08/1996 | CA2195665A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 02/08/1996 | CA2195302A1 Carbon monoxide dependent guanylyl cyclase modifiers |
| 02/08/1996 | CA2195123A1 3,4-substituted pyrazoles for the treatment of inflammation |
| 02/07/1996 | EP0695751A1 Agent acting on the central nervous system, process for its preparation and pharmaceutical compositions containing it |
| 02/07/1996 | EP0695747A1 Derivatives of substituted N-oxide 1-(7-chloroquinolin-4-yl)pyrozole-3-carboxamides as ligand of the neurotensin receptor |
| 02/07/1996 | EP0695549A1 Use of polydeoxyribonucleotides in diabetic neuropathies |
| 02/07/1996 | EP0695546A1 Powders based on metoclopramide and paracetamol or acetylsalicylic acid derivatives |
| 02/07/1996 | EP0695297A1 1,5-benzodiazepines useful as gastrin or cck-antagonists |
| 02/07/1996 | EP0695180A1 Novel medical use for gaba agonists |
| 02/07/1996 | EP0627915A4 Sprayable analgesic composition and method of use. |
| 02/07/1996 | CN1030890C Method for preparing a medicament compound |
| 02/06/1996 | US5489688 Process for preparing trans-piperidine-2,5-dicarboxylates |
| 02/06/1996 | US5489686 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II receptor antagonist properties |
| 02/06/1996 | US5489592 3,4-dihydro-4-oxo-3-(2-propenyl)-1-phthalazineacetic acids and derivatives, their preparations and medicines containing them |
| 02/06/1996 | US5489579 Potentation of NMDA antagonists |
| 02/06/1996 | CA2057456C Anti depression pharmaceutical |
| 02/05/1996 | CA2155245A1 Use of neutortensin antagonists for the preparation of diuretic drugs |
| 02/01/1996 | WO1996002555A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | WO1996002547A1 Dioxo-thiopyrano-pyridine carboxylic acid derivatives and their use as medicaments |
| 02/01/1996 | WO1996002545A1 Heterocycle-condensed morphinoid derivatives |
| 02/01/1996 | WO1996002544A1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 02/01/1996 | WO1996002537A1 Benzocondensed five membered heterocycle carboxamides as 5ht2b/2c receptor antagonists |
| 02/01/1996 | WO1996002536A1 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one derivatives as nmda antagonists |
| 02/01/1996 | WO1996002525A1 Novel aryl piperazine-derived piperazide derivatives, methods for their preparation, their use as drugs and pharmaceutical compositions comprising same |
| 02/01/1996 | WO1996002520A1 Triazole compounds and their use as dopamine-d3-ligands |
| 02/01/1996 | WO1996002519A1 Substituted pyrimidine compounds and their use |
| 02/01/1996 | WO1996002513A1 Optically active isomers of dihydrexidine and its substituted analogs |
| 02/01/1996 | WO1996002506A1 Quinoline derivatives as leukotriene antagonists |
| 02/01/1996 | WO1996002497A1 Substituted benzamidines, their production and their use as medicaments |
| 02/01/1996 | WO1996002496A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | WO1996002253A1 Dioxolenylmethyl carbamates promoieties for amine drugs |
| 02/01/1996 | WO1996002251A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
| 02/01/1996 | WO1996002248A1 Cannabinoid receptor antagonists |
| 02/01/1996 | WO1996002246A1 Use of heterocyclic compounds as dopamines-d3 ligands |
| 02/01/1996 | WO1996002238A1 Neurotropic and sedative agent and a method of obtaining the same |
| 02/01/1996 | WO1996002233A1 Immunological activity of rhamnolipids |
| 02/01/1996 | WO1995026739A3 Use of substituted dextranes for treating nervous system damage, and heparane sulphate-enriched fractions |
| 02/01/1996 | CA2560114A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | CA2195427A1 Novel aryl piperazine-derived piperazide derivatives, methods for their preparation, their use as drugs and pharmaceutical compositions comprising same |
| 02/01/1996 | CA2195242A1 The use of heterocyclic compounds |
| 02/01/1996 | CA2195241A1 Substituted pyrimidine compounds and their use |
| 02/01/1996 | CA2195239A1 Optically active isomers of dihydrexidine and its substituted analogs |
| 02/01/1996 | CA2195197A1 Corticotropin-releasing factor-binding-protein inhibitors and their use |
| 02/01/1996 | CA2195122A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
| 02/01/1996 | CA2194889A1 Dioxo-thiopyrano-pyridine carboxylic acid derivatives and their use as medicaments |
| 02/01/1996 | CA2194886A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | CA2194877A1 Heterocycle-condensed morphinoid derivatives |
| 02/01/1996 | CA2194684A1 Cannabinoid receptor antagonists |
| 02/01/1996 | CA2193661A1 Dioxolenylmethyl carbamates promoieties for amine drugs |
| 02/01/1996 | CA2192478A1 Quinoline derivatives as leukotriene antagonists |
| 01/31/1996 | EP0694546A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 01/31/1996 | EP0694545A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 01/31/1996 | EP0694536A1 1-Benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them |
| 01/31/1996 | EP0694535A1 Non-peptidyl tachykinin receptor antagonists |
| 01/31/1996 | EP0694304A1 An extract of freshwater mussel, methods of the extraction and uses thereof |
| 01/31/1996 | EP0694303A1 Use of eliprodil and its enantiomers for the preparation of medicaments useful in the prevention of neuropathies induced by anticancer agents, e.g. paclitaxel |
| 01/31/1996 | EP0694040A1 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity |
| 01/31/1996 | EP0694033A1 Indole derivatives as 5-ht1a and/or 5-ht2 ligands |
| 01/31/1996 | EP0693928A1 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
| 01/31/1996 | EP0693926A1 Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide |
| 01/31/1996 | EP0608353B1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 01/31/1996 | EP0593615B1 Aromatic compounds, compositions containing them and their use in therapy |
| 01/31/1996 | EP0593557B1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/31/1996 | CN1115982A Pharmacologically active pyridine derivatives and processes for the preparation thereof |
| 01/31/1996 | CN1115963A Cerebral metabolism activator containing glucose ester derivative |
| 01/31/1996 | CN1115761A Derivative, preparation and medical application of quinoline and imidazole |
| 01/31/1996 | CN1115759A Tricyclic carboxylate |
| 01/31/1996 | CN1115756A Method for preparing pharmaceutically active CNS compounds |
| 01/30/1996 | US5488151 {(7S)-7-[(2R)-2-(3-chlorophenyl)-2-hydroxyethylamino)-2-hydroxyethylamino]5,} acetic acid and its pharmaceutically acceptable salts |
| 01/30/1996 | US5488145 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
| 01/30/1996 | US5488099 Multifunctional chimeric neurotrophic factors |
| 01/30/1996 | US5488056 Method for treating anxiety |
| 01/30/1996 | US5488053 Tetrahydro-pyrido-indole |
| 01/30/1996 | US5488048 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ace |
| 01/30/1996 | CA2154907A1 Use of eliprodil and enantiomers thereof for the preparation of medicines useful for preventing peripheral neuropathies induced by anticancer agents |
| 01/30/1996 | CA2154906A1 Use of ifenprodil and diastereoisomers thereof for the preparation of medicines useful in the treatment of pheripheral neuropathies and central neurodegenerative diseases |
| 01/30/1996 | CA2031572C Non-alcoholic delivery system for orally ingestible active ingredients |
| 01/30/1996 | CA1338012C Pharmaceutically active amines |
| 01/28/1996 | CA2154624A1 Azaaliphatically bridged quinoxaline-2,3-diones |
| 01/25/1996 | WO1996001898A1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/25/1996 | WO1996001893A1 Recombinant kat enzyme and process for its preparation |
| 01/25/1996 | WO1996001824A1 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product |
| 01/25/1996 | WO1996001819A1 Heterocyclic tachykinin receptor antagonists |
| 01/25/1996 | WO1996001817A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 01/25/1996 | WO1996001813A1 CONFORMATIONALLY RIGID BICYCLIC AND ADAMANTANE DERIVATIVES USEFUL AS α2-ADRENERGIC BLOCKING AGENTS |
| 01/25/1996 | WO1996001652A1 Aqueous risperidone formulations |
| 01/25/1996 | WO1996001648A1 Attenuation of wound healing processes |
| 01/25/1996 | WO1996001644A1 Inhibitors of leukocyte adhesion |
| 01/25/1996 | WO1996001637A1 New pharmaceutical preparation for pain management |
| 01/25/1996 | CA2194768A1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/25/1996 | CA2194702A1 Conformationally rigid bicyclic and adamantane derivatives useful as .alpha.2-adrenergic blocking agents |